Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
Portfolio Pulse from Lara Goldstein
Cybin Inc. (NYSE:CYBN) and Small Pharma Inc. (OTCQB:DMTTF) have announced that their shareholders have approved the acquisition of Small Pharma by Cybin. The arrangement is subject to approval by BC’s Supreme Court and other customary closing conditions, with an expected effective date on or around October 23, 2023. Post-acquisition, Small Pharma will cease trading at TSXV and the OTCQB venture market.
October 13, 2023 | 5:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cybin's acquisition of Small Pharma was approved by a significant majority of shareholders. This could potentially strengthen Cybin's position in the market.
The acquisition of Small Pharma by Cybin, approved by a significant majority of shareholders, could potentially strengthen Cybin's position in the market by adding Small Pharma's assets to its portfolio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Small Pharma's shareholders have approved the company's acquisition by Cybin. Following the acquisition, Small Pharma will cease trading at TSXV and the OTCQB venture market.
The approval of Small Pharma's acquisition by Cybin by its shareholders means that Small Pharma will cease to exist as an independent entity. This will result in the cessation of its trading at TSXV and the OTCQB venture market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100